13 September 2020 Read the original media release here. A massive new support package will see $3 billion in cash grants, tax relief and cashflow support delivered to Victorian businesses as we work together to drive coronavirus cases…
11 September 2020 This information is provided by AusIndustry. Read more via AusIndustry here. Aware that COVID-19 and the recent bushfires may have affected your economic circumstances, applications for the Research and Development Tax Incentive have been extended…
10 September 2020 The directors of Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, are pleased to announce the appointment of Mr Daniel Spiegelman as an…
10 September 2020 Originally published via the University of Melbourne by Stephanie Portelli, Elston D’Souza and Associate Professor David Ascher COVID-3D, a new open-access tool harnesses SARS-CoV-2 genomic and structural information to help ensure therapeutic efforts remain effective.…
10 September 2020 Release date 9 September 2020 Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) announces the appointment of Mr Fred Bart as Non-Executive Chair, allowing ExecutiveChair and CEO, Dr Graham Kelly, to focus on the CEO…
10 September 2020 Release date 8 September 2020 New Suburban Response Units will be set up to give rapid local insights and leverage community connections to help keep localised outbreaks contained, as Victoria takes the first steps to…
10 September 2020 Release date 8 September 2020 Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) is pleased to announce that after a rigorous global search, the clinical research organisation (CRO), Parexel® Biotech, has been appointed to manage…
10 September 2020 Now is the time to look for future global opportunities Australia’s hydrogen industry is expected to contribute at least $11 billion to the national economy and generate around 7,600 jobs by 2050. In the current state of play,…
10 September 2020 Release date 4 September 2020 A phase three global clinical trial led by the Murdoch Children’s Research Institute (MCRI) has shown a new drug boosts bone growth in children born with achondroplasia, the most common type of…
10 September 2020 Release date 3 September 2020 AusBiotech welcomes its new industry Advisory Group Chairs: Dr Megan Robertson, St Vincent’s Hospital Melbourne, Chair of the AusBiotech Clinical Trials Adivsory Group; and Dr Amanda Gillon, Bioscience Managers, Chair…
7 September 2020 Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, has today announced positive efficacy data from a study of its induced pluripotent stem cell (iPSC)-derived Cymerus™ mesenchymal…
7 September 2020 PolyNovo is pleased to announce it has received a grant from the Victorian Government, Department of Jobs, Innovation and Trade for up to $252,000. This funding is to support the purchase of equipment and the…